Greenberg Traurig is a sponsor of the Breakthrough Biotech Builders session featuring Mary Lynne Hedley and moderated by William Chin. This event will explore the impact of Dr. Hedley’s work on the future of biotechnology and medicine.
The Breakthrough Biotech Builders series provides biotech founders and CEOs with a unique opportunity to engage directly with industry pioneers and learn from their experiences advancing drug candidates through successful development pathways and into the clinic.